The role of tertiary lymphoid structures in renal cell carcinoma: From predictive biomarker to therapeutic target
In the evolving landscape of cancer immunotherapy, tertiary lymphoid structures (TLS) have rapidly transitioned from a histological curiosity to a central mediator of anti-tumour …
